{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T13:44:20Z","timestamp":1791985460358,"version":"4.4.0"},"reference-count":48,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2007,2,1]],"date-time":"2007-02-01T00:00:00Z","timestamp":1170288000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Drug and Alcohol Dependence"],"published-print":{"date-parts":[[2007,2]]},"DOI":"10.1016\/j.drugalcdep.2006.07.003","type":"journal-article","created":{"date-parts":[[2006,8,25]],"date-time":"2006-08-25T22:15:54Z","timestamp":1156544154000},"page":"1-9","source":"Crossref","is-referenced-by-count":69,"title":["Clinical efficacy of gabapentin versus tiagabine for reducing cocaine use among cocaine dependent methadone-treated patients"],"prefix":"10.1016","volume":"87","author":[{"given":"Gerardo","family":"Gonz\u00e1lez","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rani","family":"Desai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mehmet","family":"Sofuoglu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jim","family":"Poling","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alison","family":"Oliveto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kishor","family":"Gonsai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas R.","family":"Kosten","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.drugalcdep.2006.07.003_bib1","doi-asserted-by":"crossref","first-page":"437","DOI":"10.2165\/00003495-199855030-00013","article-title":"Tiagabine. A review of its pharmacodynamic and pharmacokinetic properties and therapeutic potential in the management of epilepsy","volume":"55","author":"Adkins","year":"1998","journal-title":"Drugs"},{"key":"10.1016\/j.drugalcdep.2006.07.003_bib2","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1046\/j.1365-2710.2001.00325.x","article-title":"Baclofen versus clonidine in the treatment of opiates withdrawal, side-effects aspect: a double-blind randomized controlled trial","volume":"26","author":"Ahmadi-Abhari","year":"2001","journal-title":"J. Clin. Pharm. Ther."},{"key":"10.1016\/j.drugalcdep.2006.07.003_bib3","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1046\/j.1365-2710.2000.00295.x","article-title":"Double-blind randomized controlled trial of baclofen vs. clonidine in the treatment of opiates withdrawal","volume":"25","author":"Akhondzadeh","year":"2000","journal-title":"J. Clin. Pharm. Ther."},{"issue":"Suppl. 1","key":"10.1016\/j.drugalcdep.2006.07.003_bib4","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1111\/j.1360-0443.2005.00983.x","article-title":"A medication screening trial evaluation of reserpine, gabapentin and lamotrigine pharmacotherapy of cocaine dependence","volume":"100","author":"Berger","year":"2005","journal-title":"Addiction"},{"key":"10.1016\/j.drugalcdep.2006.07.003_bib5","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1016\/j.drugalcdep.2005.07.009","article-title":"A randomized placebo-controlled trial of gabapentin for cocaine dependence","volume":"81","author":"Bisaga","year":"2005","journal-title":"Drug Alcohol Depend."},{"key":"10.1016\/j.drugalcdep.2006.07.003_bib6","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1002\/syn.10278","article-title":"Treating cocaine addiction: from preclinical to clinical trial experience with gamma-vinyl GABA","volume":"50","author":"Brodie","year":"2003","journal-title":"Synapse"},{"key":"10.1016\/j.drugalcdep.2006.07.003_bib7","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1001\/jama.261.4.561","article-title":"Cocaine use and HIV infection in intravenous drug users in San Francisco","volume":"261","author":"Chaisson","year":"1989","journal-title":"JAMA"},{"key":"10.1016\/j.drugalcdep.2006.07.003_bib8","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1177\/001316446002000104","article-title":"A coefficient if agreement for nominal scales","volume":"20","author":"Cohen","year":"1960","journal-title":"Educ. Psychol. Meas."},{"key":"10.1016\/j.drugalcdep.2006.07.003_bib9","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1080\/10550490050173217","article-title":"The effect of stimulant and sedative use on treatment outcome of patients admitted to methadone maintenance treatment","volume":"9","author":"DeMaria","year":"2000","journal-title":"Am. J. Addict."},{"key":"10.1016\/j.drugalcdep.2006.07.003_bib10","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1002\/(SICI)1098-2396(199704)25:4<393::AID-SYN11>3.0.CO;2-W","article-title":"GABAergic attenuation of cocaine-induced dopamine release and locomotor activity","volume":"25","author":"Dewey","year":"1997","journal-title":"Synapse"},{"key":"10.1016\/j.drugalcdep.2006.07.003_bib11","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1002\/(SICI)1098-2396(199810)30:2<119::AID-SYN1>3.0.CO;2-F","article-title":"A novel strategy for the treatment of cocaine addiction","volume":"30","author":"Dewey","year":"1998","journal-title":"Synapse"},{"key":"10.1016\/j.drugalcdep.2006.07.003_bib12","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/S0006-8993(99)02183-6","article-title":"[3H] tiagabine binding to GABA uptake sites in human brain","volume":"851","author":"Eriksson","year":"1999","journal-title":"Brain Res."},{"key":"10.1016\/j.drugalcdep.2006.07.003_bib13","series-title":"Structured Clinical Interview for DSM-IV","author":"First","year":"1995"},{"issue":"Suppl. 3","key":"10.1016\/j.drugalcdep.2006.07.003_bib14","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1046\/j.1528-1157.2001.042suppl.3042.x","article-title":"Tiagabine in clinical practice","volume":"42","author":"Genton","year":"2001","journal-title":"Epilepsia"},{"key":"10.1016\/j.drugalcdep.2006.07.003_bib15","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1016\/S0014-2999(01)00800-7","article-title":"GABAergic blockade of cocaine-associated cue-induced increases in nucleus accumbens dopamine","volume":"414","author":"Gerasimov","year":"2001","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.drugalcdep.2006.07.003_bib16","doi-asserted-by":"crossref","first-page":"1625","DOI":"10.1046\/j.1360-0443.2003.00544.x","article-title":"Tiagabine increases cocaine-free urines in cocaine-dependent methadone-treated patients: results of a randomized pilot study","volume":"98","author":"Gonzalez","year":"2003","journal-title":"Addiction"},{"key":"10.1016\/j.drugalcdep.2006.07.003_bib17","doi-asserted-by":"crossref","first-page":"1547","DOI":"10.2165\/00003495-200464140-00004","article-title":"Agents in development for the management of cocaine abuse","volume":"64","author":"Gorelick","year":"2004","journal-title":"Drugs"},{"key":"10.1016\/j.drugalcdep.2006.07.003_bib18","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1046\/j.1360-0443.2003.00296.x","article-title":"The National treatment outcome research study (NTORS): 4\u20135 year follow-up results","volume":"98","author":"Gossop","year":"2003","journal-title":"Addiction"},{"key":"10.1016\/j.drugalcdep.2006.07.003_bib19","doi-asserted-by":"crossref","first-page":"15","DOI":"10.3109\/00952999709001685","article-title":"Patterns and predictors of cocaine and crack use by clients in standard and enhanced methadone maintenance treatment","volume":"23","author":"Grella","year":"1997","journal-title":"Am J Drug Alcohol Abuse"},{"key":"10.1016\/j.drugalcdep.2006.07.003_bib20","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1016\/j.drugalcdep.2003.10.015","article-title":"Gabapentin maintenance decreases smoked cocaine-related subjective effects, but not self-administration by humans","volume":"73","author":"Hart","year":"2004","journal-title":"Drug Alcohol Depend"},{"key":"10.1016\/j.drugalcdep.2006.07.003_bib21","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/0169-2607(96)01720-8","article-title":"MIXOR: a computer program for mixed-effects ordinal regression analysis","volume":"49","author":"Hedeker","year":"1996","journal-title":"Comput. Methods Programs Biomed."},{"key":"10.1016\/j.drugalcdep.2006.07.003_bib22","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1016\/0169-2607(96)01723-3","article-title":"MIXREG: a computer program for mixed-effects regression analysis with autocorrelated errors","volume":"49","author":"Hedeker","year":"1996","journal-title":"Comput. Methods Programs Biomed."},{"key":"10.1016\/j.drugalcdep.2006.07.003_bib23","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1016\/j.drugalcdep.2004.03.008","article-title":"A pilot trial of topiramate for the treatment of cocaine dependence","volume":"75","author":"Kampman","year":"2004","journal-title":"Drug Alcohol Depend."},{"key":"10.1016\/j.drugalcdep.2006.07.003_bib24","doi-asserted-by":"crossref","first-page":"457","DOI":"10.2307\/2281868","article-title":"Nonparametric estimation from incomplete observation","volume":"53","author":"Kaplan","year":"1958","journal-title":"J. Am. Stat. Assoc."},{"key":"10.1016\/j.drugalcdep.2006.07.003_bib25","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3109\/00952998509016845","article-title":"Comparison of clinician ratings to self reports of withdrawal during clonidine detoxification of opiate addicts","volume":"11","author":"Kosten","year":"1985","journal-title":"Am. J. Drug Alcohol Abuse"},{"key":"10.1016\/j.drugalcdep.2006.07.003_bib26","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1136\/jnnp.74.3.339","article-title":"A controlled study comparing visual function in patients treated with vigabatrin and tiagabine","volume":"74","author":"Krauss","year":"2003","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"10.1016\/j.drugalcdep.2006.07.003_bib27","doi-asserted-by":"crossref","first-page":"931","DOI":"10.1046\/j.1360-0443.2002.00209.x","article-title":"Pharmacological treatment of cocaine dependence: a systematic review","volume":"97","author":"Lima","year":"2002","journal-title":"Addiction"},{"key":"10.1016\/j.drugalcdep.2006.07.003_bib28","first-page":"403","article-title":"Baclofen as a cocaine anti-craving medication: a preliminary clinical study","volume":"18","author":"Ling","year":"1998","journal-title":"Neuropsychopharmacology."},{"key":"10.1016\/j.drugalcdep.2006.07.003_bib29","doi-asserted-by":"crossref","first-page":"1198","DOI":"10.2307\/2290157","article-title":"A test of missing completely at random for multivariate data with missing values","volume":"83","author":"Little","year":"1988","journal-title":"J. Am. Stat. Assoc."},{"key":"10.1016\/j.drugalcdep.2006.07.003_bib30","doi-asserted-by":"crossref","first-page":"1927","DOI":"10.1081\/JA-120016225","article-title":"Treating cocaine-using methadone patients: predictors of outcomes in a psychosocial clinical trial","volume":"37","author":"Magura","year":"2002","journal-title":"Subst Use Misuse"},{"key":"10.1016\/j.drugalcdep.2006.07.003_bib31","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1016\/j.pnpbp.2003.11.020","article-title":"Add-on gabapentin in the treatment of opiate withdrawal","volume":"28","author":"Martinez-Raga","year":"2004","journal-title":"Prog. Neuropsychopharmacol. Biol. Psychiatry"},{"key":"10.1016\/j.drugalcdep.2006.07.003_bib32","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1016\/0740-5472(92)90062-S","article-title":"The Fifth Edition of the Addiction Severity Index","volume":"9","author":"McLellan","year":"1992","journal-title":"J. Subst. Abuse Treat."},{"key":"10.1016\/j.drugalcdep.2006.07.003_bib33","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1097\/00005053-198001000-00006","article-title":"An improved diagnostic evaluation instrument for substance abuse patients. The Addiction Severity Index","volume":"168","author":"McLellan","year":"1980","journal-title":"J. Nervous Mental Dis."},{"key":"10.1016\/j.drugalcdep.2006.07.003_bib34","doi-asserted-by":"crossref","first-page":"19","DOI":"10.4088\/JCP.v62n0105","article-title":"Gabapentin in the treatment of cocaine dependence: a case series","volume":"62","author":"Myrick","year":"2001","journal-title":"J. Clin. Psychiatry"},{"key":"10.1016\/j.drugalcdep.2006.07.003_bib35","doi-asserted-by":"crossref","first-page":"185","DOI":"10.2307\/2344317","article-title":"Asymptomatically efficient rank invariant test procedures","volume":"135","author":"Peto","year":"1972","journal-title":"J. R. Stat. Soc. [A]."},{"key":"10.1016\/j.drugalcdep.2006.07.003_bib36","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1002\/ana.410390114","article-title":"The effect of gabapentin on brain gamma-aminobutyric acid in patients with epilepsy","volume":"39","author":"Petroff","year":"1996","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.drugalcdep.2006.07.003_bib37","doi-asserted-by":"crossref","first-page":"2058","DOI":"10.1176\/appi.ajp.157.12.2058-a","article-title":"Gabapentin therapy for cocaine cravings","volume":"157","author":"Raby","year":"2000","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.drugalcdep.2006.07.003_bib38","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1177\/014662167700100306","article-title":"A CES-D Scale: a self-reported depression scale for reaserch in the general population","volume":"I","author":"Radloff","year":"1977","journal-title":"Appl. Psychol. Meas."},{"key":"10.1016\/j.drugalcdep.2006.07.003_bib39","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1046\/j.0003-2409.2001.02399.x","article-title":"Gabapentin: pharmacology and its use in pain management [Review]","volume":"57","author":"Rose","year":"2002","journal-title":"Anaesthesia"},{"key":"10.1016\/j.drugalcdep.2006.07.003_bib40","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1016\/S0740-5472(96)00096-7","article-title":"Follow-up of inpatient cocaine withdrawal for cocaine-using methadone patients","volume":"13","author":"Rosenblum","year":"1996","journal-title":"J. Subst. Abuse. Treat."},{"key":"10.1016\/j.drugalcdep.2006.07.003_bib41","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1080\/10550490050172218","article-title":"Importance of identifying cocaine and alcohol dependent methadone clients","volume":"9","author":"Rowan-Szal","year":"2000","journal-title":"Am. J. Addict."},{"issue":"Suppl. 5","key":"10.1016\/j.drugalcdep.2006.07.003_bib42","doi-asserted-by":"crossref","first-page":"S17","DOI":"10.1111\/j.1528-1157.1999.tb00915.x","article-title":"Tiagabine","volume":"40","author":"Schachter","year":"1999","journal-title":"Epilepsia"},{"key":"10.1016\/j.drugalcdep.2006.07.003_bib43","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1517\/14656566.2.1.179","article-title":"Pharmacology and clinical experience with tiagabine [Review]","volume":"2","author":"Schachter","year":"2001","journal-title":"Expert Opin. Pharmacother."},{"key":"10.1016\/j.drugalcdep.2006.07.003_bib44","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1212\/WNL.57.2.196","article-title":"Visual field constriction: accumulation of vigabatrin but not tiagabine in the retina","volume":"57","author":"Sills","year":"2001","journal-title":"Neurology"},{"key":"10.1016\/j.drugalcdep.2006.07.003_bib45","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1016\/S0920-1211(97)00084-3","article-title":"A summary of mechanistic hypotheses of gabapentin pharmacology","volume":"29","author":"Taylor","year":"1998","journal-title":"Epilepsy Res."},{"key":"10.1016\/j.drugalcdep.2006.07.003_bib46","doi-asserted-by":"crossref","first-page":"887","DOI":"10.1097\/00002030-200304110-00014","article-title":"Intensive injection cocaine use as the primary risk factor in the Vancouver HIV-1 epidemic","volume":"17","author":"Tyndall","year":"2003","journal-title":"AIDS"},{"issue":"Suppl. 1","key":"10.1016\/j.drugalcdep.2006.07.003_bib47","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1111\/j.1360-0443.2005.00992.x","article-title":"A placebo-controlled screening trial of tiagabine, sertraline and donepezil as cocaine dependence treatments","volume":"100","author":"Winhusen","year":"2005","journal-title":"Addiction"},{"key":"10.1016\/j.drugalcdep.2006.07.003_bib48","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1016\/j.drugalcdep.2004.08.018","article-title":"Assessing missing data assumptions in longitudinal studies: an example using a smoking cessation trial","volume":"77","author":"Yang","year":"2005","journal-title":"Drug Alcohol Depend."}],"container-title":["Drug and Alcohol Dependence"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0376871606002766?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0376871606002766?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,1,13]],"date-time":"2019-01-13T23:57:12Z","timestamp":1547423832000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0376871606002766"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,2]]},"references-count":48,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2007,2]]}},"alternative-id":["S0376871606002766"],"URL":"https:\/\/doi.org\/10.1016\/j.drugalcdep.2006.07.003","relation":{},"ISSN":["0376-8716"],"issn-type":[{"value":"0376-8716","type":"print"}],"subject":[],"published":{"date-parts":[[2007,2]]}}}